NewYork-Presbyterian Hospital: Experimental Gene Therapy Reverses Sickle Cell Disease for Years
December 14, 2021
December 14, 2021
NEW YORK, Dec. 14 (TNSJou) -- NewYork-Presbyterian Hospital issued the following news release:
An experimental gene therapy for sickle cell disease restored blood cells to their normal shape and eliminated severe pain crises for years after treatment, a multicenter study has found.
A study of an investigational gene therapy for sickle cell disease has found that a single dose restored blood cells to their normal shape and eliminated the most serious complication of the . . .
An experimental gene therapy for sickle cell disease restored blood cells to their normal shape and eliminated severe pain crises for years after treatment, a multicenter study has found.
A study of an investigational gene therapy for sickle cell disease has found that a single dose restored blood cells to their normal shape and eliminated the most serious complication of the . . .